Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy

F Pea, P Viale, F Pavan, M Furlanut - Clinical pharmacokinetics, 2007 - Springer
Continuous renal replacement therapy (CRRT), particularly continuous venovenous
haemofiltration (CVVH) and continuous venovenous haemodiafiltration (CVVHDF), are …
被引用次数：253 相关文章

[引用][C] Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy

F PEA, P VIALE, F PAVAN, M FURLANUT - 2007 - ricerca.unityfvg.it

Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy.

F Pea, P Viale, F Pavan, M Furlanut - Clinical Pharmacokinetics, 2007 - europepmc.org
Continuous renal replacement therapy (CRRT), particularly continuous venovenous
haemofiltration (CVVH) and continuous venovenous haemodiafiltration (CVVHDF), are …

Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy

F Pea, P Viale, F Pavan, M Furlanut - Clinical Pharmacokinetics, 2007 - hero.epa.gov
Continuous renal replacement therapy (CRRT), particularly continuous venovenous
haemofiltration (CVVH) and continuous venovenous haemodiafiltration (CVVHDF), are …

[引用][C] Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy

F PEA - Clin Pharmacokinet, 2007 - cir.nii.ac.jp
Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement
therapy | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …

Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy

F Pea, P Viale, F Pavan… - Clinical …, 2007 - pubmed.ncbi.nlm.nih.gov
Continuous renal replacement therapy (CRRT), particularly continuous venovenous
haemofiltration (CVVH) and continuous venovenous haemodiafiltration (CVVHDF), are …

[引用][C] Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy

F Pea, P Viale, F Pavan, M Furlanut, F Pea - CLINICAL …, 2007 - air.uniud.it
Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement
therapy IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore Titolo Riviste Serie IT Italiano …

Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy

F Pea, P Viale, F Pavan, M Furlanut, F Pea - CLINICAL …, 2007 - cris.unibo.it
Continuous renal replacement therapy (CRRT), particularly continuous venovenous
haemofiltration (CVVH) and continuous venovenous haemodiafiltration (CVVHDF), are …

[引用][C] Pharmacokinetic Considerations for Antimicrobial Therapy in Patients Receiving Renal Replacement Therapy

F PEA, P VIALE, F PAVAN… - Clinical …, 2007 - pascal-francis.inist.fr
Pharmacokinetic Considerations for Antimicrobial Therapy in Patients Receiving Renal
Replacement Therapy CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …

Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy.

F Pea, P Viale, F Pavan, M Furlanut - 2007 - cabidigitallibrary.org
Continuous renal replacement therapy (CRRT), particularly continuous venovenous
haemofiltration (CVVH) and continuous venovenous haemodiafiltration (CVVHDF), are …